Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology Article Report uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Lung Neoplasms
  • Lymphoma, Large-Cell, Anaplastic

abstract

  • This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.

authors

publication date

  • April 2017

Research

keywords

  • Report

Identity

PubMed ID

  • 28404761

Additional Document Info

start page

  • 504

end page

  • 535

volume

  • 15

number

  • 4